| Literature DB >> 24714795 |
Vanessa Cristina Miranda Takahagi, Daniela Caetano Costa, Júlio César Crescêncio, Lourenço Gallo Junior.
Abstract
BACKGROUND: Characterized as a sudden and temporary loss of consciousness and postural tone, with quick and spontaneous recovery, syncope is caused by an acute reduction of systemic arterial pressure and, therefore, of cerebral blood flow. Unsatisfactory results with the use of drugs allowed the nonpharmacological treatment of neurocardiogenic syncope was contemplated as the first therapeutic option.Entities:
Mesh:
Year: 2014 PMID: 24714795 PMCID: PMC3987313 DOI: 10.5935/abc.20140021
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Antropometric characteristics and basal hemodynamic parameters in the trained group (TG) and control group (CG)
|
|
| |
|---|---|---|
|
|
| |
| Male | 2 | 1 |
| Female | 9 | 9 |
| Age (years) | 32 (10) | 26 (8) |
| Height (cm) | 164 (9.4) | 163.5 (5.5) |
| Body mass (kg) | 67 (11.2) | 63 (10.0) |
| Heart rate (bpm) | 64 (8) | 65 (7) |
| Systolic arterial pressure (mmHg) | 110.9 (17.1) | 109.0 (17.1) |
| Diastolic arterial pressure (mmHg) | 71.8 (12.7) | 69.0 (11.0) |
SD: Standard deviation.
Description of the variables measured in the ergospirometric test before and after intervention in the trained group (TG) and control group (CG)
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
|
|
| HR rest | 10 | 65 | 7 | 11 | 56 | 63 | 77 |
| HR peak | 10 | 168 | 14 | 9 | 143 | 173 | 183 | ||
| VO2 peak | 10 | 24.3 | 7.55 | 31.06 | 16 | 22.95 | 40 | ||
| VO2 AT | 10 | 12.4 | 3.27 | 26.39 | 8 | 12 | 20 | ||
|
| HR rest | 10 | 66 | 6 | 9 | 59 | 65 | 82 | |
| HR peak | 10 | 169 | 17 | 10 | 123 | 172 | 181 | ||
| VO2 peak | 10 | 22.84 | 7.25 | 31.72 | 14.3 | 22 | 38 | ||
| VO2 AT | 10 | 11.8§ | 3.12 | 26.44 | 9 | 11 | 19 | ||
|
|
| HR rest | 11 | 64 | 8 | 12 | 51 | 66 | 78 |
| HR peak | 11 | 162 | 16 | 10 | 133 | 166 | 180 | ||
| VO2 peak | 11 | 21,1† | 4.02 | 19.03 | 14 | 21.15 | 26.8 | ||
| VO2 AT | 11 | 12‡ | 1.48 | 12.36 | 9 | 12 | 14 | ||
|
| HR rest | 11 | 66 | 10 | 15 | 52 | 64 | 83 | |
| HR peak | 11 | 169 | 10 | 6 | 150 | 171 | 181 | ||
| VO2 peak | 11 | 25.35† | 3.93 | 15.51 | 21.6 | 25 | 34.8 | ||
| VO2 AT | 11 | 14.27‡§ | 2.28 | 16 | 10 | 14 | 19 |
SD: standard deviation; CV: coefficient of variation; HR: heart rate; AT: anaerobic threshold; † p ≤ 0.05; VO2 peak in the trained group before and after the intervention. ‡ p ≤ 0.05; VO2 at AT in the trained group before and after the intervention. § p ≤ 0.05; VO2 at AT between the control and trained groups after the intervention.
Figure 1Number of syncope episodes in the trained group and control group in the 3 periods under study.
Results of the head-up tilt test before and after the intervention in the trained group (TG) and control group (CG)
|
|
| |||
|---|---|---|---|---|
|
|
|
|
| |
| Positive | 11 (100%) | 3 (27.3%) | 10 (100%) | 7 (70%) |
| Negative | 0 | 8 (72.7%)[ | 0 | 3 (30%)[ |
p ≤ 0.05; HUT result between the TG and CG after the intervention.
Orthostasis tolerance time before and after the intervention in the trained group (TG) and control group (CG)
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|
|
|
| 10 | 31.3 | 12.9 | 41.2 | 9 | 35.5 | 44 |
|
| 10 | 27.6* | 13.6 | 49.3 | 4 | 25.5 | 45 | |
|
|
| 11 | 28.6† | 13.8 | 48.0 | 8 | 32 | 44 |
|
| 11 | 39.5*† | 9.9 | 25.1 | 18 | 45 | 45 |
SD: standard deviation; CV: coefficient of variation; *p ≤ 0.05; orthostasis tolerance time (min) after the intervention between the CG and TG. † p ≤ 0.05; orthostasis tolerance time in the TG before and after the intervention.